FDA
-
-
-
-
-
-
-
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
-
-
-
-
-
-
-
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
-
-
-
-
-
-
-
Renalytix Reports Full Year Fiscal 2022 Results
-
-
-
-
-
-
-
Renalytix (RENX) Says 1,112 Patient Study Demonstrates Clinical Utility, Care Benefits of KidneyIntelX Risk Stratification in Stage 1 to 3 DKD Patients
-
-
-
-
-
-
-
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
-
-
-
-
-
-
-
Renalytix to Appoint Timothy Scannell to Board of Directors
-
-
-
-
-
-
-
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
-
251,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All